Serum concentrations of TNF-α are also found to be upregulated in AD and in MCI34, and increased TNF-α serum levels have an associated four-fold greater rate of cognitive decline than AD patients with low baseline TNF-α35. The gene discussed is TNF; the disease is Alzheimer disease.